Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CBIO | CTMX |
|---|---|---|
| Price | $13.49 | $2.55 |
| Change today | ▼ 0.59% | ▼ 0.39% |
| Market cap | $501.07M | $555.64M |
| Return, 3 months | -19.5% | -35.5% |
| Return, year to date | +13.7% | -40.1% |
| Return, 1 year | +11.9% | -24.3% |
| P/E (TTM) | -96.4 | -4.5 |
| P/B | 3.1 | 1.8 |
| P/E percentile vs own 5y | – | 25th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | -92.4% |
| Net profit growth (YoY) | – | -13,319.5% |
| Gross margin | – | – |
| Operating margin | – | -476.2% |
| Net margin | – | -435.2% |
| Return on equity | – | -37.8% |
| Analyst target vs. price | +120.5% | +419.6% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 32 | 32 |
| 30-day volatility | 74.1% | 72.2% |
| Max drawdown, 1 year | -50.0% | -62.2% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
